http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2591256-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c15f333f816af7b657e325964cca235c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10 |
filingDate | 2015-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdfd4767da4825398cddc15a76ce0089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03ae95ae3abcbb0e6c26c4b7ac99c7fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3418f60b9f40ec2e3f1b94e67aca69b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a38850c04f3ef59b57329d468e8ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f3c629e4a6f0c257699ef8b8f9b8b91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6cfc9e499b60618f7b74f0113f2d2fe |
publicationDate | 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2591256-C1 |
titleOfInvention | α,ω-BIS(AMIDE- AND HYDRAZIDE METHYL SULFINYL- AND SULPHONYL) ALKANES HAVING ANTI-TUBERCULOSIS ACTIVITY, AND α,ω-BIS(METHOXY CARBONYL METHYL SULFINYL- OR SULPHONYL) ALKANES FOR PRODUCTION THEREOF |
abstract | FIELD: chemistry. n SUBSTANCE: invention relates to sulphur-containing dicarboxylic acids of formula (1) n n n n wherein: X=NH 2 , m=1, n=2, 3, 4, 5, 6, 7, 8, 10; X=NH 2 , m=2, n=1, 2, 3, 4, 5, 6, 7, 8, 10; X=NHNH 2 , m=1, n=1, 2, 3, 5, 6, 7, 8, 10; X=NHNH 2 , m=2, n=1, 2, 3, 4, 5, 6, 7, 8, 10. Invention also relates to sulphur-containing dicarboxylic acids of formula (2) n n n n wherein: m=1, n=2, 3, 4, 5, 6, 7, 8, 10; m=2, n=3, 4, 5, 6, 7, 8, 10; used for producing compounds of formula (1). n EFFECT: compounds of formula (1) have high tuberculostatic activity, including in relation to multi-drug resistant Mycobacteria strains, low toxicity and simplicity of synthesis. n 3 cl, 2 tbl, 59 ex |
priorityDate | 2015-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 85.